Industry Seeks More Clarity Following Combo Product GMP Final Rule
This article was originally published in The Gray Sheet
Executive Summary
FDA’s final regulation outlines which manufacturing system requirements apply to products that have drug, device and/or biologic components. An industry coalition says key details need to be filled in by FDA with guidance.